2 unchanged sentences
Incorporated by Reference
−Removed: Loan Agreement by and between HCW Biologics Inc.
−Removed: and Cogent Bank, dated August 15, 2022.
−Removed: Mortgage and Security Agreement by and between HCW Biologics Inc.
−Removed: and Cogent Bank, dated August 15, 2022.
−Removed: Capital on Demand TM Sales Agreement, dated August 19, 2022, by and between HCW Biologics Inc.
−Removed: and Jones Trading Institutional Services LLC
+Added: Development Line of Credit Agreement, dated as of April 20, 2023 by and between Prime Capital Ventures, LLC and HCW Biologics Inc.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language):
−Removed: (i) the Condensed Balance Sheets as of December 31, 2021 and September 30, 2022 (unaudited);
−Removed: (ii) the Condensed Statements of Operations for the three months and nine months ended September 30, 2021 (unaudited) and September 30, 2022 (unaudited);
−Removed: (iv) the Condensed Statements of Stockholders’
−Removed: Equity for the three and nine months ended September 30, 2021 (unaudited) and September 30, 2022 (unaudited);
−Removed: (v) the Condensed Statements of Cash Flows for the nine months ended September 30, 2021 (unaudited) and September 30, 2022 (unaudited);
+Added: The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language):
+Added: (i) the Condensed Balance Sheets as of December 31, 2022 and March 31, 2023 (unaudited);
+Added: (ii) the Condensed Statements of Operations for the three months ended March 31, 2022 (unaudited) and March 31, 2023 (unaudited);
+Added: (iv) the Condensed Statements of Changes in Stockholders’
+Added: Equity for the three months ended March 31, 2022 (unaudited) and March 31, 2023 (unaudited);
+Added: (v) the Condensed Statements of Cash Flows for the three months ended March 31, 2022 (unaudited) and March 31, 2023 (unaudited);
and (vi) the notes to the Condensed Financial Statements (unaudited).
3 unchanged sentences
HCW Biologics Inc.
−Removed: November 7, 2022
Chief Executive Officer
(Principal Executive Officer)
−Removed: November 7, 2022
/s/ Rebecca Byam
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.